# A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of Hyperkalemia

> **NCT04780841** · PHASE2 · COMPLETED · sponsor: **Ardelyx** · enrollment: 109 (actual)

## Conditions studied

- Hyperkalemia

## Interventions

- **DRUG:** RDX013
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04780841
- **Lead sponsor:** Ardelyx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-11
- **Primary completion:** 2021-12-28
- **Final completion:** 2022-03-03
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2022-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04780841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04780841, "A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of Hyperkalemia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04780841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*